Reduction in frequency of fetopathic effects of caffeine in mice by pretreatment with propranolol.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000818:Animals; D002110:Caffeine / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000633:toxicity*; D002395:Catecholamines / Q000037:antagonists & inhibitors; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D008431:Maternal-Fetal Exchange; D051379:Mice; D008813:Mice, Inbred ICR; D011247:Pregnancy; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use*; D013723:Teratogens
D002395:Catecholamines; D013723:Teratogens; D002110:Caffeine; D011433:Propranolol